Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

Cited by (676)

Items 401–500 of 676

1. Single-cell sequencing of plasma cells from COVID-19 patients reveals highly expanded clonal lineages produce specific and neutralizing antibodies to SARS-CoV-2
   Roy A. Ehling, Cédric R. Weber, Derek M. Mason, Simon Friedensohn, Bastian Wagner, Florian Bieberich, Edo Kapetanovic, Rodrigo Vazquez-Lombardi, Raphaël B. Di Roberto, Kai-Lin Hong et al. · 2021 · bioRxiv
2. Evidence for Deleterious Antigenic Imprinting in SARS-CoV-2 Immune Response
   Sanjana R. Sen, Emily C. Sanders, Alicia M. Santos, Keertna Bhuvan, Derek Y. Tang, Aidan A. Gelston, Brian M. Miller, Joni Ricks‐Oddie, Gregory A. Weiss · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
3. The Delta Variant Had Negligible Impact on COVID-19 Vaccine Effectiveness in the USA
   B. Blaiszik, Carlo Graziani, J. Olds, Ian T. Foster · 2021 · medRxiv
4. Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
   Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, Akanksha A. Shanbhag, Milos Matkovic, Maira Biggiogero, Pier Andrea Maida, Jacques Moritz, Chiara Toscano, Elaheh Ghovehoud et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
5. Humanity over economy: biopolitical responses to the COVID-19 pandemic in Ghana
   James C. McKeown · 2022 · Working Paper Series
6. Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice
   Maria V. Sergeeva, Kirill Vasilev, Ekaterina Romanovskaya-Romanko, Nikita D. Yolshin, Anastasia Pulkina, Daria Shamakova, Anna-Polina S. Shurygina, Arman Muzhikyan, Dmitry A. Lioznov, Marina Stukova · 2024 · Vaccines
7. Deciphering the autoreactome: Massively parallelized methods for autoantibody detection in humans
   Nicolai V Hörstke, Thomas J. Vogl · 2025 · Journal of Immunological Methods
8. A SARS‐CoV‐2 Neutralization Assay Using Single Molecule Arrays
   Tal Gilboa, Limor Cohen, Chi‐An Cheng, Roey Lazarovits, Augusta Uwamanzu‐Nna, Isaac Han, Kettner Griswold, Nick Barry, David B. Thompson, Richie E. Kohman et al. · 2021 · Angewandte Chemie
9. Country Wise Measures in Contrast to The Spread of SARS-COV2/COVID-19
   Hindustan Abdul Ahad, Haranath Chinthaginjala, Bhavani Haribabu Sai Dharani, Momin Umaira Ayisha, Chukkaluri Anu Reddy, Gandhodi Chandra Manasa, Nandini Nandini · 2022 · Asian Journal of Research in Pharmaceutical Sciences
10. “Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19”
    Ladan Mansouri, Senka Sendic, Sebastian Havervall, Charlotte Thålin, Stefan H. Jacobson, Joachim Lundahl · 2022 · BMC Nephrology
11. CasPlay provides a gRNA-barcoded CRISPR-based display platform for antibody repertoire profiling
    Karl W. Barber, Ellen L. Shrock, Stephen Joseph Elledge · 2022 · Cell Reports Methods
12. Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based Vaccine
    Hua‐Rui Gong, Ye‐Fan Hu, Xuechen Li, Thomas C. C. Yau, Bao‐Zhong Zhang, Jian-Dong Huang · 2022 · ACS Infectious Diseases
13. Identification of Closed Linear Epitopes in S1-RBD and S2-HR1/2 of SARS-CoV-2 Spike Protein Able to Induce Neutralizing Abs
    Yoshihiro Watanabe, Natsuko Hosokawa, Misaki Yoshida, Tomoyuki Miura, Mitsuhiro Kawano · 2023 · Vaccines
14. Pathogen Discovery in the Post-COVID Era
    Cheng Guo, Jianyong Wu · 2024 · Pathogens
15. Advances in researches on long coronavirus disease in children: a narrative review
    Jiaqian Zhang, Taiji Kuang, Xinglou Liu · 2024 · Translational Pediatrics
16. A Peptide Microarray Platform Approach for Discovery of Immunodominant Antibody Epitopes
    Phillip Stafford, Nisha D. Sherma, Milene Peterson, Chris W. Diehnelt · 2024 · Analytical Chemistry
17. Antibody Response against the SARS-CoV-2 Nucleocapsid Protein and Its Subdomains—Identification of Pre-Immunization Status by Human Coronaviruses with Multipanel Nucleocapsid Fragment Immunoblotting
    Sahra Pajenda, Sebastian Kapps, Thomas Reiter, Raimundo Freire, Veronique A. J. Smits, Ludwig Wagner, Daniela Gerges, Wolfgang Winnicki, Gere Sunder–Plassmann, Alice Schmidt · 2021 · COVID
18. Evaluation of a Novel Multiplex Platform for Simultaneous Detection of IgG Antibodies Against the 4 Main SARS-CoV-2 Antigens
    Vijayalakshmi Nandakumar, Tracie Profaizer, Bucky K. Lozier, Marc Elgort, Jenna A. Rychert, Patricia R. Slev, Julio C. Delgado · 2021 · The Journal of Applied Laboratory Medicine
19. Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
    Yinon Levy, Ron Alcalay, Anat Zvi, Efi Makdasi, Eldar Peretz, Tal Noy-Porat, Theodor Chitlaru, Michal Mandelboim, Ohad Mazor, Ronit Rosenfeld · 2022 · Vaccines
20. Characteristics and Potential Roles of Natural Killer Cells During SARS-CoV-2 Infection
    Wenjing Cao, Fu‐Sheng Wang, Jin‐Wen Song · 2022 · Infectious Diseases & Immunity
21. Predicting the risk of primary Sjögren's syndrome with key N7-methylguanosine-related genes: A novel XGBoost model
    Hui Xie, Yin-mei Deng, Jiao-yan Li, Kaihong Xie, Tao Tan, Jianfang Zhang · 2024 · Heliyon
22. Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates
    Xaquín Castro Dopico, Sandra Muschiol, Nastasiya F. Grinberg, Soo Aleman, Daniel J. Sheward, Leo Hanke, Marcus Ahl, Linnea Vikström, Mattias N.E. Forsell, Jonathan M. Coquet et al. · 2022 · Clinical & Translational Immunology
23. Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19
    Lingyun Chen, Pengfei Pang, Huan Qi, Keqiang Yan, Yan Ren, Ming‐liang Ma, Ruyin Cao, Hua Li, Chuansheng Hu, Yang Li et al. · 2022 · Frontiers in Immunology
24. Neutralizing antibody responses against SARS-CoV-2 in vaccinated people with multiple sclerosis
    Tirisham Victoria Gyang, John Parker Evans, Joseph S. Miller, Kariss Alcorn, Juan Peng, Erica Hlavin Bell, Cong Zeng, Richard J. Gumina, Shan‐Lu Liu, Benjamin M. Segal · 2022 · Multiple Sclerosis Journal - Experimental Translational and Clinical
25. Probabilistic approaches for classifying highly variable anti-SARS-CoV-2 antibody responses
    Xaquín Castro Dopico, Leo Hanke, Daniel J. Sheward, Sandra Muschiol, Soo Aleman, Nastasiya F. Grinberg, Mónika Ádori, Murray Christian, Laura Perez Vidakovics, Changil Kim et al. · 2020 · medRxiv
26. Systemic and mucosal immune signatures of protection against SARS-CoV-2 transmission in humans
    Amaya Rojo-Fernandez, Sadaf Aslam, Fahmida Alam, Alba Escalera, Vicente Villamandos, Beatriz Caton, Gregoria Megías, Angel Gonzalez, Luís Buzón, Juan Ayllón et al. · 2025 · Cell Reports Medicine
27. Immunogenicity assessment and epitope mapping of the ASFV proteome by profiling serum antibodies with ASFV antigen phage libraries
    Lerong Ma, Zhen Weng, Yuanzhu Zhang, Zhi Cao, Xingjun Ke, Ruize Sun, Yin Xie, Mengjie Lian, Lin Yang, Hongming Yuan et al. · 2026 · Communications Biology
28. Elevated binding and functional antibody responses to SARS-CoV-2 in infants versus mothers
    Caitlin I. Stoddard, Kevin Sung, Zak A. Yaffe, Haidyn Weight, Guillaume Beaudoin-Bussières, Jared Galloway, Soren M. Gantt, Judith Adhiambo, Emily R. Begnel, Ednah Ojee et al. · 2023 · Nature Communications
29. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals
    Flávia Lopes Adami, Mateus Vidigal de Castro, Bianca da Silva Almeida, Isabela Pazotti Daher, Márcio Massao Yamamoto, Keity Souza Santos, Mayana Zatz, Michel Satya Naslavsky, Daniela Santoro Rosa, Edécio Cunha‐Neto et al. · 2024 · Frontiers in Immunology
30. Phage Immunoprecipitation and Sequencing—a Versatile Technique for Mapping the Antibody Reactome
    Gustav N. Sundell, Sheng‐ce Tao · 2024 · Molecular & Cellular Proteomics
31. Petrophysical prediction of oil reservoirs using explainable artificial intelligence
    Shengge Li, Zhen Wei, Yanqing Yang, Ji Zhang, Yuanfeng Cheng · 2025 · Geophysics
32. Prevalence of viral co-infection among COVID-19 cases in association disease severity and oral hygiene
    Zeina Sami Adham, Batool Hassan Al-Ghurabi · 2021 · Journal of Baghdad College of Dentistry
33. Multicomponent vaccines to fight SARS-CoV-2 variants of concern
    Antonio Cassone, Roberto Cauda · 2021 · Vaccine
34. B-Cell Responses in Hospitalized Severe Acute Respiratory Syndrome Coronavirus 2–Infected Children With and Without Multisystem Inflammatory Syndrome
    Nadine Peart Akindele, Lisa Pieterse, San Suwanmanee, Diane E. Griffin · 2022 · The Journal of Infectious Diseases
35. Immune and pathophysiologic profiling of antenatal coronavirus disease 2019 in the GIFT cohort: A Singaporean case-control study
    Yue Gu, Jia Ming Low, Jolene S.Y. Tan, Melissa Shu Feng Ng, Lisa F. P. Ng, Bhuvaneshwari D O Shunmuganathan, Rashi Gupta, Paul A. MacAry, Zubair Amin, Le Ye Lee et al. · 2022 · Frontiers in Pediatrics
36. Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19
    Ji Qiu, Anna L Engelbrektson, Lusheng Song, Jin Park, Vel Murugan, Stacy A. Williams, Yunro Chung, Ericka Nelly Pompa-Mera, Jorge Luis Sandoval-Ramírez, José Antonio Mata Marín et al. · 2023 · Microbiology Spectrum
37. Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients
    Salum J. Lidenge, Dicle Yalcin, Sydney J. Bennett, Owen Ngalamika, Brenda B. Kweyamba, Chacha John Mwita, For Yue Tso, Julius David Mwaiselage, John T. West, Charles A. Wood · 2024 · Viruses
38. Coxsackievirus A7 and Enterovirus A71 Significantly Reduce SARS-CoV-2 Infection in Cell and Animal Models
    Victor A. Svyatchenko, Stanislav S. Legostaev, Roman Y. Lutkovskiy, Е. В. Протопопова, Eugenia P. Ponomareva, Vladimir V. Omigov, Oleg Svyatoslavovich Taranov, Vladimir A. Ternovoi, Alexander P. Agafonov, Valery B. Loktev · 2024 · Viruses
39. Does accrual information impact municipal bond prices? Evidence from Japan using AI
    Kentaro Haraguchi, Yasuhiro Tamba, Daisuke Ikeda, Shuji Abe · 2024 · Public Money & Management
40. Autoantibodies in COVID‐19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives
    Srijan Chatterjee, Manojit Bhattacharya, Sanskriti Saxena, Sang‐Soo Lee, Chiranjib Chakraborty · 2024 · Reviews in Medical Virology
41. Predictions, Pivots, and a Pandemic: a Review of 2020's Top Translational Bioinformatics Publications
    Scott McGrath, Mary Lauren Benton, Maryam Tavakoli, Nicholas P. Tatonetti · 2021 · Yearbook of Medical Informatics
42. Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection
    Kyu-Young Sim, Gwang-Hoon Ko, So-Eun Bae, Kyu Yeong Choi, Jung Sup Lee, Byeong Chae Kim, Kun Ho Lee, Mi‐Ryoung Song, Sung‐Gyoo Park · 2022 · Frontiers in Immunology
43. A case‐series of six autopsy cases of COVID‐19 including three cases of cytomegalovirus coinfection
    Jotaro Nakashima, Yuichiro Kadomatsu, Shingo Itagaki, Toshinori Otani, Takahiro Kiriu, Atsumi Matsunaga, Saya Munakata, Haruka Okada · 2022 · Pathology International
44. Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?
    Arup Acharjee, Joshua Stephen Kingsly, Madhura Kamat, Vishakha Kurlawala, Aparajita Chakraborty, Priyanka Vyas, Radhika Vaishnav, Sanjeeva Srivastava · 2022 · Expert Review of Proteomics
45. Virome Analysis and Association of Positive Coxsackievirus B Serology during Pregnancy with Congenital Heart Disease
    Mathieu Garand, Susie S.Y. Huang, Lisa Smith Goessling, Fei Wan, Donna Ann Santillan, Mark K. Santillan, Anoop K. Brar, Todd Wylie, Kristine M. Wylie, Pirooz Eghtesady · 2023 · Microorganisms
46. Predictive Analysis of the Neutralization Activity in Convalescent Plasmas From COVID-19 Recovered Patients in Zhejiang Province, China, January-March, 2020
    Yajie Yuan, Liang Yu, Zi Jin, Yongjun Wang, Meng Qiu Gao, Haojie Ding, Xunhui Zhuo, Xiao Ming Zhu, Fei Gao, Xiaojun Zheng et al. · 2021 · Frontiers in Cellular and Infection Microbiology
47. Anti‐SARS‐CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1?
    Nicolas Vuilleumier, Sabrina Pagano, Burkhard Ludewig, K. Schmiedeberg, Christoph Haller, Johannes von Kempis, Andrea Rubbert‐Roth · 2021 · European Journal of Clinical Investigation
48. Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals
    A. Karim Embong, Phuong Quoc Thuc Nguyen, Jiong Wang, Preshetha Kanagaiah, Francisco A. Chaves, Theresa F. Fitzgerald, Qian Zhou, Gabrielle Kosoy, Angela R Branche, Benjamin L. Miller et al. · 2022 · Pathogens
49. A flexible, pan-species, multi-antigen platform for the detection and monitoring of SARS-CoV-2-specific antibody responses
    Huifeng Shen, David Forgacs, Digantkumar Gopaldas Chapla, Kelley W. Moremen, Lance Wells, Sarah A. Hamer, Stephen Mark Tompkins, Ted M. Ross, Nadine Rouphael, Srilatha Edupuganti et al. · 2021 · medRxiv
50. Why decoding the immune response to COVID matters for vaccines
    2020 · Nature
51. Faradaic Impedimetric Immunosensor for Label-Free Point-of-Care Detection of Covid-19 Antibodies Using a Gold Interdigitated Electrode Array
    Lian C. T. Shoute, Carmen L. Charlton, Jamil N. Kanji, Shawn Babiuk, Lorne Babiuk, Jie Chen · 2023 · SSRN Electronic Journal
52. The power of AI in viral vaccine production: A paradigm shift in efficiency and costs
    Bappi Sarkar · 2024 · Methods in microbiology
53. Impact of the COVID-19 pandemic on number of deaths in Ghana: an application of ARIMA with intervention analysis
    Christian Akrong Hesse, Emmanuel Dodzi Kpeglo, Dominic Buer Boyetey, Saralees Nadarajah · 2025 · Frontiers in Public Health
54. PhIP-Seq: unveiling the complexity of antibody repertoires in health and disease
    Wenjie Tang, Qijing Gai, Junjie Yang, Jianqing Chen, Zhengbing Lyu · 2026 · Frontiers in Immunology
55. Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins
    Stephen Findlay‐Wilson, Linda Easterbrook, Sandra Susan Smith, Neville Pope, Gareth Humphries, Holger Schuhmann, Didier Ngabo, Emma L. Rayner, Ashley David Otter, Tom Coleman et al. · 2022 · Antiviral Research
56. Potential use of endemic human coronaviruses to stimulate immunity against pathogenic SARS-CoV-2 and its variants
    Narges Sadat Shamabadi, Anisah B. Bagasra, Shrikant Pawar, Omar Bagasra · 2023 · Libyan Journal of Medicine
57. Detection of Antibodies against Endemic and SARS-CoV-2 Coronaviruses with Short Peptide Epitopes
    Michael Szardenings, Nicolas Delaroque, Karolin Kern, Lisbeth Ramírez Caballero, Marcus Puder, Eva Ehrentreich‐Förster, Joachim Beige, Sebastian Zürner, Georg Popp, Johannes Wolf et al. · 2023 · Vaccines
58. Phage Immunoprecipitation Sequencing (PhIP-Seq) for Analyzing Antibody Epitope Repertoires Against Food Antigens
    Ioanna N. Filimonova, Gabriel Innocenti, Thomas J. Vogl · 2023 · Methods in molecular biology
59. Development of a potent recombinant scFv antibody against the SARS-CoV-2 by in-depth bioinformatics study: Paving the way for vaccine/diagnostics development
    Fatemeh Yaghoobizadeh, Mohammad Roayaei Ardakani‬, Mohammad Mehdi Ranjbar, Mohammad Khosravi, Hamid Galehdari · 2024 · Computers in Biology and Medicine
60. Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study
    Rolando Herrero, Romain Fantin, Viviana Loría, Amada Aparicio, D. Rebecca Prevots, Michael Zúñiga, Roy Wong, Melvin Morera, Julia Butt, Marco Binder et al. · 2025 · BMC Infectious Diseases
61. Aging and Viral Evolution Impair Immunity Against Dominant Pan‐Coronavirus‐Reactive T Cell Epitope
    Lucie Loyal, Karsten Jürchott, Ulf Reimer, Lil Meyer‐Arndt, Larissa Henze, Norbert Mages, Jak Kostrzanowski, Bernhard Reus, Maike Mangold, Beate Kruse et al. · 2025 · European Journal of Immunology
62. Humoral cross-coronavirus responses against the S2 region in children with Kawasaki disease
    Ajit Monteiro, Arthur J. Chang, R. Ross Welliver, Sarah W. Baron, Mark Daniel Hicar · 2022 · Virology
63. Epitope Mapping on Microarrays Highlights a Sequence on the N Protein with Strong Immune Response in SARS-CoV-2 Patients
    Roberto Frigerio, Angelo Musicò, Alessandro Strada, Alessandro Mussida, Paola Gagni, Greta Bergamaschi, Marcella Chiari, Luisa Barzon, Alessandro Gori, Marina Cretich · 2022 · Methods in molecular biology
64. Refocus on Immunogenic Characteristics of Convalescent COVID-19 Challenged by Prototype SARS-CoV-2
    Xiaorong Huang, Chumin Liang, Manman Li, Huimin Chen, Zhaowan Li, Qianqian Ruan, Ximing Hu, Lilian Zeng, Huifang Lin, Wei Zhao et al. · 2023 · Vaccines
65. Revisiting the COVID-19 Pandemic: An Insight into Long-Term Post-COVID Complications and Repurposing of Drugs
    Rajib Majumder, Sanmitra Ghosh, Manoj Kumar Singh, Arpita Das, Swagata Roy Chowdhury, Abinit Saha, Rudra P. Saha · 2023 · COVID
66. Nonlinear interdependence of the results of measuring anti-SARS-CoV-2 IgG levels using Abbott and Euroimmun test systems
    А. В. Иванов, E. Kryshen, E. V. Semenova · 2023 · Journal of Clinical Virology
67. A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts
    Peter Lorenz, Felix Steinbeck, Franz Mai, Emil Christian Reisinger, Brigitte Müller‐Hilke · 2023 · Frontiers in Immunology
68. A novel precision-serology assay for SARS-CoV-2 infection based on linear B-cell epitopes of Spike protein
    Samuel B. Lundin, Hanna Kann, Alma Fulurija, Björn Andersson, Sravya Sowdamini Nakka, Lars‐Magnus Andersson, Magnus Gisslén, Ali M. Harandi · 2023 · Frontiers in Immunology
69. Modeling the sequence dependence of differential antibody binding in the immune response to infectious disease
    Robayet Chowdhury, Alexander T. Taguchi, Laimonas Kelbauskas, Phillip Stafford, Chris W. Diehnelt, Zhan‐Gong Zhao, Phillip C. Williamson, Valerie Green, Neal W. Woodbury · 2023 · PLoS Computational Biology
70. Individual Immune Response to SARS-CoV-2 Infection—The Role of Seasonal Coronaviruses and Human Leukocyte Antigen
    Karla Rottmayer, Henry Loeffler‐Wirth, Thomas Gruenewald, Ilias I.N. Doxiadis, Claudia Lehmann · 2023 · Biology
71. The molecular mimicry and COVID-19
    В. Н. Зорина · 2023 · Russian Journal of Infection and Immunity
72. Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein
    Guilherme Curty Lechuga, Jairo Ramos Temerozo, Paloma Napoleão-Pêgo, João P. R. S. Carvalho, Larissa Rodrigues Gomes, Dumith Chequer Bou‐Habib, Carlos Medicis Morel, David William Provance, Thiago Moreno L. Souza, Salvatore G. De-Simone · 2024 · International Journal of Molecular Sciences
73. Experimental Identification of Immuno- dominant B-cell Epitopes from SARS-CoV-2
    Lluc Farrera Soler, Jean‐Pierre Daguer, Sofía Barluenga, Nicolas Winssinger · 2021 · CHIMIA International Journal for Chemistry
74. Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV
    Samuel R Schnittman, Wonyeong Jung, Kathleen V. Fitch, Markella V. Zanni, Sara McCallum, Jessica Shih-Lu Lee, Sally A. Shin, Brandon J. Davis, Evelynne S. Fulda, Marissa R Diggs et al. · 2023 · JCI Insight
75. A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States
    Adam A. Capoferri, Wei Shao, Jon Spindler, John M. Coffin, Jason W. Rausch, Mary F. Kearney · 2022 · Viruses
76. Antibody Reactivity Against SARS-CoV-2 in Adults from the Vancouver Metropolitan Area, Canada
    Abdelilah Majdoubi, Sarah E. O’Connell, Christina Michalski, Sarah Dada, Sandeep Narpala, Jean Pierre Gelinas, Disha Mehta, Claire Cheung, Manjula Basappa, Matthias Görges et al. · 2020 · SSRN Electronic Journal
77. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
78. Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike
    Patrick C. Wilson, Siriruk Changrob, Yanbin Fu, Jenna J. Guthmiller, Peter Halfmann, Lei Li, Christopher T. Stamper, Haley L. Dugan, Molly A. Accola, William M. Rehrauer et al. · 2021 · Research Square
79. Prevalence, persistence, and genetics of antibody responses to protein toxins and virulence factors
    Julia W. Angkeow, Daniel R. Monaco, Athena Chen, Thiagarajan Venkataraman, Sahana Jayaraman, Cristian Valencia, Brandon M. Sie, Thomas Liechti, Payam Noroozi Farhadi, Gabriela Funez-dePagnier et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
80. BBIBP-CorV (Sinopharm) vaccination- induced immunity is affected by age, gender and prior COVID-19 and activates responses to spike and other antigens
    Zahra Hasan, Kiran Iqbal Masood, Shama Qaiser, Erum Khan, Areeba Hussain, Zara Ghous, Unab Inayat Khan, Maliha Yameen, Imran Hassan, Muhammad Imran Nasir et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
81. Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concern
    Payton A. B. Weidenbacher, Natalia Friedland, Mrinmoy Sanyal, Mary Kate Morris, Jonathan Do, Carl Veith Hanson, Peter S. Kim · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
82. Severity-dependent IgG epitope profiling in COVID-19 reveals differential recognition of pathogen-derived antigens
    Lais Alves do Nascimento, NicolleRakanidis Machado, João Vitor da Silva Borges, Beatriz Oliveira Fagundes, Isabela Siuffi Bergamasco, Fábio da Ressureição Sgnotto, André Luís Lacerda Bachi, Maria Notomi Sato, Jefferson Russo Victor · 2025 · Frontiers in Immunology
83. Long-Term Thyroid Complications Post-COVID-19: A Systematic Review
    Luai Hommos, Harsh Gohil, Mlaak Rob, Jane Manyama, Haneen Ramy, Nesha Naseem, Hana Nishan, Raghad Sabaawi Ibrahim, Shahad Sabaawi Ibrahim, Vivian Chetachi Eziefula Njoku et al. · 2026 · Microorganisms
84. Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort
    Jamie A. Sugrue, Céline Posseme, Ziyang Tan, Christian Pou, Bruno Charbit, Vincent Bondet, Nollaig M. Bourke, Petter Brodin, Darragh Duffy, Cliona O’Farrelly · 2022 · Cell Reports Medicine
85. "Original Antigenic Sin" in SARS-CoV-2 Vaccination Followed by Infection
    Yandy Marx Castillo‐Aleman, Carlos Agustín Villegas Valverde, Yendry Ventura‐Carmenate, Gisela María Suárez, Antonio Alfonso Bencomo‐Hernandez · 2022 · Cureus
86. Investigating the correlation between COVID-19 and the progression of chronic liver disease
    Cyriac Abby Philips, Deepak Madhu, Philip Augustine · 2023 · Expert Review of Gastroenterology & Hepatology
87. Experimental Identification of Cross-Reacting IgG Hotspots to Predict Existing Immunity Evasion of SARS-CoV-2 Variants by a New Biotechnological Application of Phage Display
    Marek Adam Harhala, Katarzyna Gembara, Krzysztof Baniecki, Aleksandra Pikies, Artur Nahorecki, Natalia Jędruchniewicz, Zuzanna Maria Kaźmierczak, Izabela Rybicka, Tomasz Klimek, Wojciech Witkiewicz et al. · 2023 · Viruses
88. Deisolation in the Healthcare Setting Following Recent COVID-19 Infection
    Samuel Baumgart, Aidan R McLachlan, Hayden Kenny, Genevieve L. McKew, Susan Maddocks, Wen Chen, Jen Kok · 2024 · Viruses
89. Epitope profiling of cow's milk allergen-specific antibodies with determining IgE content in epitopes-ALL, a 14-epitopes mixture
    Yoshihiro Watanabe, Ikuo Okafuji, Satoko Tamai, Natsuko Hosokawa, Takako Ohbayashi, Shigeki Kato, Kiyoaki Ito, Mitsuhiro Kawano, Yusei Ohshima · 2024 · Journal of Immunological Methods
90. Different patterns of leukocyte immune responses to infection of ancestral SARS-CoV-2 and its variants
    Yuanyuan Wu, Raphael Serna, Wenqi Gan, Zhichao Fan · 2025 · Frontiers in Cellular and Infection Microbiology
91. A Genome‐Wide Screening of Novel Immunogenic TrLSDV103 Protein of Lumpy Skin Disease Virus and Its Application for DIVA
    Xinwei Yuan, Junhua Dong, Zhijie Xiang, Qian Zhang, Tao Pan, Aizhen Guo · 2025 · The FASEB Journal
92. Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
    Kar Muthumani, Ziyang Xu, Moonsup Jeong, Joel N. Maslow, Vaniambadi S. Kalyanaraman, Alagarsamy Srinivasan · 2021 · Translational Medicine Communications
93. Artificial Intelligence in Clinical Immunology
    Aaron T. Chin, Nicholas L. Rider · 2022 · Springer eBooks
94. RECAST: Study protocol for an observational study for the understanding of the increased REsilience of Children compared to Adults in SARS-CoV-2 infecTion
    Sebastian Stricker, Niklas Ziegahn, Martin Karsten, Thomas Boeckel, Heike Stich-Boeckel, Jakob Maske, Evelyn Rugo, Anita Balázs, Pamela Millar-Büchner, Chantip Dang‐Heine et al. · 2023 · BMJ Open
95. Genetic Associations with Coronavirus Susceptibility and Disease Severity
    Fatima Barmania, Juanita Mellet, Megan A. Holborn, Michael Sean Pepper · 2023 · Advances in experimental medicine and biology
96. Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins
    Zulfiia E. Afridonova, А. П. Топтыгина, Ilya Sergeevich Mikhaylov · 2024 · Biochemistry (Moscow)
97. COVID-19 Infection and Disease Severity not associated with Increased Parity among Pregnant Women
    Katharine A. Marsden, Patrick P. Ten Eyck, Timothy N. Maxwell, Claire N. Castaneda, Kimberly Ann Kenne, Samantha R. Swartz, Haley Alaine Steffen, Anna E. Merrill, Matthew D. Krasowski, Abbey S. Merryman et al. · 2021 · Journal of Medical - Clinical Research & Reviews
98. ELIPSE-COL: A novel ELISA test based on rational envisioned synthetic peptides for detection of SARS-CoV-2 infection in Colombia
    Adriana Arévalo, Carlos Franco-Muñoz, Sofía Duque-Beltrán, Lyda Muñoz-Galindo, María T. Herrera-Sepúlveda, José Manuel Lozano, Luz Mary Salazar, Martha Lucía Ospina Martínez, Marcela Mercado · 2020 · medRxiv
99. Seroreactivity to SARS-CoV-2 in individuals attending a university campus in Bogotá Colombia
    John Mario González, Juan Carlos Santos‐Barbosa, Catherine Jaller, German Otalora, Luis Jorge Hernandéz, Marcela Guevara‐Suarez, Silvia Restrepo · 2021 · medRxiv
100. Epidemic trends of SARS-CoV-2 modulated by economic activity, ethnicity, and vaccination
     Yasuhiko Kamikubo, Atsushi Takahashi · 2021